Report #2869446

Overview

Sex

Female

Age

Age unknown

State

FL

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Weakness of arms; received Arexvy last year and that she was given Arexvy again this year; This non-serious case was reported by a consumer via call center representative and described the occurrence of weakness of arms in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Previously administered products included Arexvy (received Arexvy last year). On an unknown date, the patient received the 2nd dose of Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced weakness of arms (Verbatim: Weakness of arms) and extra dose administered (Verbatim: received Arexvy last year and that she was given Arexvy again this year). The outcome of the weakness of arms was unknown and the outcome of the extra dose administered was not applicable. It was unknown if the reporter considered the weakness of arms to be related to Arexvy. It was unknown if the company considered the weakness of arms to be related to Arexvy. Additional Information: GSK receipt date: 13-OCT-2025 The patient reported that, received Arexvy last year and that she was given Arexvy again this year. The patient reported that after she received the vaccine her arm was really weak. The batch number was not provided and a request for this information has been made.